Growth Faltering Intervention Using Pediatric Nutritional Care (PNC) vs.PNC& FSMP
Clinical Trial on Intervention Growth Faltering Using Pediatric Nutritional Care Compared to Pediatric Nutritional Care and Food for Special Medical Purposes (FSMP)
1 other identifier
interventional
188
1 country
1
Brief Summary
Study will be done by consortium of pediatrician from Indonesia, Japan, and Germany. This team will act as leaders while the field assistant will consist of nutritionist and general practitioner. The chosen primary endpoint is the improvement of weight for age (grams) of the sample after one month of intervention. Participants are weight faltering babies aged 6-12 months at study entry, with the weight increments below P 15th of WHO weight increments tables whose parents agreed to be included in the study by providing written informed consent.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 4, 2022
CompletedFirst Posted
Study publicly available on registry
May 26, 2022
CompletedStudy Start
First participant enrolled
August 17, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 23, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedFebruary 26, 2024
February 1, 2024
9 months
April 4, 2022
February 22, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Weight increment difference in grams
to look for the relative efficacy of PNC and PNC + FSMP (SGM 100) on the weight increments
one month
Secondary Outcomes (12)
weight increment percentile
during study period (3 months)
length increments in cm
during study period (3 months)
body mass index in kg/m^2
during study period (3 months)
Composition (proportion) of each type of microorganisms in fecal
baseline, one month
level of metabolites in faecal (faecal metabolome)
baseline and one month in the study
- +7 more secondary outcomes
Study Arms (2)
PNC (Pediatric Nutrition Care)
PLACEBO COMPARATORThis first group will be given pediatric nutrition care (PNC) in visit 0. In this group parents will receive nutritional advice about how many calories are needed, the type and form of food that can be given so that the baby can gain weight accordingly.
FSMP (Food for Special Medical Purposes) & PNC (Pediatric Nutrition Care)
ACTIVE COMPARATORIn this second group, subject will receive PNC in visit 0 and food for special medically purposes/FSMP that will be given according to daily calorie needs which are determined based on ideal body weight (BB) according to body length. In general, FSMP will be given 3 times a day, according to the needs of each subject. Parents will be taught about preparation of FSMP e.g. dissolving and the correct amount of product (image will be attached in the appendix). FSMP will be given during the research period and will be discontinued when not needed anymore.
Interventions
High dense nutrients formula: Powder based Infant formula with High Nutrients' Density with energy density of 100 kcal/100ml and for Pediatric Nutrition Care: A medical service to understand nutritional status, problems related to the feeding process and clinical diagnosis of the patient.
Pediatric Nutrition Care: A medical service to understand nutritional status, problems related to the feeding process and clinical diagnosis of the patient.
Eligibility Criteria
You may qualify if:
- Weight faltering babies (weight increments below percentile 15th of weight increments table WHO age 6-12 month-old with good nutritional or mild undernutrition status
- Have a growth chart monitoring (weight, length and head circumference) at least one time (at birth).
- Have the data of height and weight from father and mother (genetic height potential)
- Not suffered from parasitic manifestation by examining the faecel sample at the time of recruitment
- Parents want to follow the study by signing the informed consent
You may not qualify if:
- Subjects with stunting
- Subject in the severe disease condition at the time of recruitment
- Severe acute malnutrition
- Parents do not want to participate in the study
- Presence of cow's milk allergy
- Presence of lactose intolerance
- Presence of galactosemia
- Condition needing a special diet, like major renal and hepatic dysfunction
- Have conditions that will influence the nutritional status such as moderate to severe dehydration, organomegaly, oedema.
- Babies with weight more than ideal body weight
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Danone Specialized Nutrition Indonesialead
- Hasanuddin Universitycollaborator
- RIKENcollaborator
- LMU Klinikumcollaborator
Study Sites (1)
Hasanuddin University
Makassar, South Sulawesi, 90245, Indonesia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Conny Tanjung, MD, PhD
Hasanuddin University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 4, 2022
First Posted
May 26, 2022
Study Start
August 17, 2022
Primary Completion
May 23, 2023
Study Completion
December 31, 2024
Last Updated
February 26, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share